Related Deals
Related Parents
Related Issuers
by Chris Reich
Feb 25, 2026 12:23 PM ET
AstraZeneca Finance LLC (AZN) exp A1/A+ (s/s) US$ benchmark SEC registered 3-part sr notes (5y FXD due 3/2/31, 7y FXD due 3/2/33 and 10y FXD due 3/2/36). MWC then 1mo par call on 5y (2/2/31), 2mos on 7y (1/2/33) and 3mos on 10y (12/2/35). BofA (B&D)/DB/HSBC/Miz joint active books. Guarantor: AstraZeneca PLC. Denoms: 2,000 x 1,000. Sales into Canada: Yes, via exemption. Listing: New York Stock Exchange. UOP: General corporate purposes, which may include the refinancing of existing indebtedness.Pricing 2/25. Settle 3/2 (T+3).
IPTs: 5y T+65 area, 7y T+75 area, 10y T+85 area.
GUIDANCE: 5y T+42#, 7y T+52#, 10y T+60#.